News Archives - Page 480 of 746

TuesdayFeb 16, 2021 2:28 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Outlines 2021 Business Strategies for COVID-19 PCR Testing and Psychedelic Treatments

XPhyto Therapeutics Corp. plans to commercialize its rapid and portable PCR Kit this year to provide point-of-care diagnostics The company is confident about the successful validation of the PCR kit for the European commercial (CE-IVD) approval in Q1 2021 Hugh Rogers, CEO and Director of XPhyto, revealed in the latest news release that the company will make investments and development of psychedelic treatments XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is a bioscience accelerator involved in the development of new pharmaceuticals, diagnostic products, and psychedelic medicine. As a part of its business strategy for the year 2021, the company…

TuesdayFeb 16, 2021 2:13 pm

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Delineates Parameters and Timeline of Study into Psilocybin-Based Active Treatments

Pure Extract Technologies pursues study into psilocybin active treatments Study to extend for 250-day period, targeting a number of milestones The study is set to be carried out at Toronto Institute of Pharmaceutical Technology, will be supervised by Pure Extracts’ scientific advisor, Dr. Alexander MacGregor Oregon recently voted to legalize psilocybin mushrooms for therapeutic use, a potential legislative movement which may soon be replicated in other jurisdictions Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, and functional mushroom sectors, has provided investors with an update in regards to its ongoing…

TuesdayFeb 16, 2021 12:48 pm

SRAX Inc. (NASDAQ: SRAX) Sequire Platform Provides Exclusive Access to B. Riley Vision Day Content; Company Announces Closing on BIGtoken Transaction

As host to B. Riley’s Securities’ 2021 Vision Day, SRAX offers event content to Sequire community SRAX CEO states that B. Riley event is “perfect example of our growing Virtual Event Platform capabilities” Definitive agreement between SRAX-created BIGtoken, FPVD closes SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, concluded its role as the exclusive technology host for B. Riley Securities’ 2021 Vision Day (https://ibn.fm/D7R3c); sessions from the event are available exclusively to B. Riley clients and investors on the Sequire platform. The company also announced that its BIGtoken platform…

TuesdayFeb 16, 2021 11:36 am

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Plant-Based Biopesticide Achieves 100% Control of Root-Rot Disease in Recent Studies

Most recent tests show MustGrow’s patented biopesticide achieved 100% control over Aphanomyces within 24 hours Plant-based biopesticide uses natural defense mechanism found in mustard seed to control diseases, pests and weeds MustGrow hoping to provide valuable crop-protection tool for pulse-crop farmers MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has announced that its plant-based biopesticide has achieved 100% control of root-rot disease in a recent round of laboratory tests (https://ibn.fm/WJo4p). MustGrow, an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops such as fruits and vegetables, is focused on providing natural, science-based biological solutions to replace synthetic…

FridayFeb 12, 2021 3:20 pm

CNS Pharmaceuticals (NASDAQ: CNSP) Celebrates IND Status, Prepares to Launch Brain Cancer Drug Trials

Brain cancer drug developer CNS Pharmaceuticals is celebrating recent news that the U.S. Food and Drug Administration (“FDA”) granted investigational new drug (“IND”) status to CNS Pharmaceuticals’ leading candidate for fighting glioblastomas Glioblastomas are a class of aggressive brain cancers with no known cure and a median life expectancy of 14 to 16 months following diagnosis The FDA’s decision to grant CNSP’s request for IND status clears the way for the company to begin human clinical trials within the next couple of months The company’s sublicensee partner, WPD Pharmaceuticals, will also prepare a first-ever Phase I trial for drug safety…

FridayFeb 12, 2021 3:07 pm

Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) Builds Momentum in its PowerTap Investment as Andretti Agreement Takes Off

Canada’s Clean Power Capital Corp., a holding company focused on investing in the renewable energy sector, recently increased its equity interest in California’s PowerTap Hydrogen Fueling Corp. from 90 percent to 94.5 percent PowerTap inked an agreement last month with the companies collectively comprising the Andretti Group, operated by auto racing legends Mario and Michael Andretti to situate and market PowerTap’s hydrogen fueling technology PowerTap followed up on the agreement by appointing Michael Andretti to the company board PowerTap recently announced the strategy behind its business model, focusing on profit motivations for the retail locations where the fueling stations will…

FridayFeb 12, 2021 2:53 pm

Grapefruit USA Inc. (GPFT) Rolls Out Hourglass by Grapefruit in Greater Los Angeles; Poised to Sustain Rapid Growth

Grapefruit expands availability of patented Hourglass by Grapefruit(TM) product to Greater Los Angeles area Hourglass is manufactured only at Grapefruit's Coachillin facility, available only through Grapefruit authorized retailers GPFT achieved robust growth in 2020, poised to continue momentum going forward as demand remains strong Grapefruit USA (OTCQB: GPFT), a premier fully licensed California-based company, has announced that its patented Hourglass time-release THC+Cannabinoid infused topical delivery cream has been rolled out to additional licensed retail cannabis locations in the Greater Los Angeles area (https://ibn.fm/ZohgC). Hourglass is manufactured exclusively at Grapefruit's Coachillin facility and available only through Grapefruit authorized retailers. The company…

FridayFeb 12, 2021 2:37 pm

Brain Scientific Inc. (BRSF) Establishing New Innovative Norms for Clinicians

Bergen Neurology Consultants utilized BRSF’s devices to improve patient care Minimal training means more staff can administer, monitor the EEG; more appointments can be scheduled Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company focused on developing innovative and proprietary medical devices and software, has created two devices designed to disrupt the EEG market. The NeuroCap(TM) and NeuroEEG(TM) offer cost-effective, disposable substitutes that help improve patient’s access to neurological care. The company is also helping improve the quality of care and solutions that practices can offer their patients. An example of the impact of the device can be seen through Bergen…

FridayFeb 12, 2021 2:24 pm

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Featured in “Forbes,” Receives First National Mainstream News Exposure

“Forbes” highlights TAAT’s journey, value as alternative to tobacco cigarettes for smokers aged 21+ Among smokers aged 21+, most prefer smoking experience to vaping, are looking for nonaddictive alternatives TAAT is seeing a pattern of repeat customers, reorders from retailers Famed Reddit stock trader Keith Gill, identified as one of investors behind recent rise of GameStop, listed TAAT ticker symbols in his notebook, which was photographed in news article earlier this month TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF), a company that is dedicated to giving smokers aged 21+ a nicotine-free and tobacco-free smoking experience, was featured in “Forbes”…

Site Search

Company Search

Category: News